Company intelligence
Nitto BioPharma
Innovation for Customers
Biotechnology Research
San Diego, US
39 employees
6 public signals
About Nitto BioPharma
Nitto BioPharma Inc. offers unique drug and nucleic acid (siRNA, miRNA, mRNA, etc) delivery solutions by designing novel biodegradable delivery vehicles with the combined ability to target specific cells and efficiently deliver a therapeutic moiety to the cells.
Verified activity
Signals from Nitto BioPharma
6 published signals
Presence & Recognition
Nitto BioPharma is attending the 7th Annual Genome Editing Therapeutics Summit in Boston from September 28-30, 2026.
Reported by Nitto BioPharma
Presence & Recognition
Nitto BioPharma is attending BioJapan 2026 to connect with innovators advancing nonviral RNA/DNA-based delivery and cell and gene therapies.
Reported by Nitto BioPharma
Presence & Recognition
Nitto BioPharma is attending the CELL & GENE MEETING ON THE MESA 2026 in Phoenix, AZ from October 5 to 7.
Reported by Nitto BioPharma
Presence & Recognition
Nitto BioPharma announced that its LNP Technologies will be featured at the 3rd Annual Gene Therapy Initiative Symposium 2026 in La Jolla, California.
Reported by Nitto BioPharma
Presence & Recognition
Nitto BioPharma announced that Noriko Kanaya will serve as a Featured Chair at the 3rd Annual Gene Therapy Initiative Symposium 2026 at the Salk Institute in San Diego, California on September 16.
Reported by Nitto BioPharma
Presence & Recognition
Nitto BioPharma announced that Noriko Kanaya will give a poster presentation titled In Vivo Selective Gene Editing of Hematopoietic Stem Cells Using CD117-Targeted Lipid Nanoparticles at the 3rd Annual Gene Therapy Initiative Symposium 2026 on September 16.
Reported by Nitto BioPharma